QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
NASDAQ:MTCR

Metacrine - MTCR News Today

$0.53
+0.03 (+6.18%)
(As of 01/31/2023 05:19 PM ET)
Add
Compare
Today's Range
$0.51
▼
$0.53
50-Day Range
$0.35
▼
$0.50
52-Week Range
$0.30
▼
$0.68
Volume
721,312 shs
Average Volume
358,261 shs
Market Capitalization
$22.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Metacrine News Delivered to You Automatically

Sign up to receive the latest news and ratings for MTCR and its competitors with MarketBeat's FREE daily newsletter.



MTCR Media Mentions By Week

MTCR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MTCR
News Sentiment
▼
0.16

0.72
▲
Average
Medical
News Sentiment

MTCR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MTCR Articles
This Week
▼
6

0
▲
MTCR Articles
Average Week

SourceHeadline
MarketBeat logoMetacrine, Inc. (NASDAQ:MTCR) Insider Michael York Sells 107,054 Shares
americanbankingnews.com - January 28 at 7:19 AM
MarketBeat logoPreston Klassen Sells 380,605 Shares of Metacrine, Inc. (NASDAQ:MTCR) Stock
americanbankingnews.com - January 28 at 6:32 AM
finance.yahoo.com logoMetacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement
finance.yahoo.com - December 23 at 7:51 PM
finanznachrichten.de logoMetacrine, Inc.: Metacrine Reports Third-Quarter 2022 Results
finanznachrichten.de - November 17 at 6:47 AM
finance.yahoo.com logoMetacrine Reports Third-Quarter 2022 Results
finance.yahoo.com - November 15 at 11:05 AM
finance.yahoo.com logoEquillium Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis - Yahoo Finance
finance.yahoo.com - September 28 at 7:39 PM
benzinga.com logoLifshitz Law PLLC Announces Investigations of TALO, SBET, EQ, and MTCR - Metacrine (NASDAQ:MTCR), Equilli - Benzinga
benzinga.com - September 25 at 12:13 AM
benzinga.com logoLifshitz Law PLLC Announces Investigations of RMED, SBET, EQ, and MTCR - Metacrine (NASDAQ:MTCR), Equilli - Benzinga
benzinga.com - September 22 at 6:52 AM
marketwatch.com logoLifshitz Law PLLC Announces Investigations of RMED, SBET, EQ, and MTCR - MarketWatch
marketwatch.com - September 21 at 8:52 PM
benzinga.com logoLifshitz Law PLLC Announces Investigations of RMED, SBET, EQ, and MTCR - Metacrine (NASDAQ:MTCR), Equillium (NASDAQ:EQ) - Benzinga
benzinga.com - September 17 at 7:53 PM
benzinga.com logoMETACRINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Metacrine Inc. - MTCR
benzinga.com - September 8 at 12:38 PM
globenewswire.com logoSHAREHOLDER NOTICE: Halper Sadeh LLP Investigates STR, MNRL, EQ, MTCR - GlobeNewswire
globenewswire.com - September 7 at 10:11 AM
benzinga.com logoApexigen, Inc. - Common Stock (APGN), (AQST), (ATIP), (ATXI), Cardiff Oncology, Inc. - Common Stock (CRDF - Benzinga
benzinga.com - September 7 at 12:07 AM
finance.yahoo.com logoEquillium to Acquire Metacrine in All-Stock Transaction - Yahoo Finance
finance.yahoo.com - September 7 at 12:07 AM
seekingalpha.com logoEquillium acquires Metacrine to extend cash runway through 2024 (NASDAQ:MTCR) - Seeking Alpha
seekingalpha.com - September 7 at 12:07 AM
technews.tmcnet.com logoMTCR Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Metacrine Inc. Is Fair to Shareholders
technews.tmcnet.com - September 6 at 7:07 PM
finance.yahoo.com logoMetacrine, Inc. (MTCR)
finance.yahoo.com - September 5 at 10:19 PM
benzinga.com logoMetacrine: Q2 Earnings Insights - Benzinga
benzinga.com - August 10 at 4:16 AM
benzinga.com logoMetacrine Reports Second-Quarter 2022 Results - Benzinga
benzinga.com - August 9 at 11:15 PM
finance.yahoo.com logoMetacrine Reports Second-Quarter 2022 Results
finance.yahoo.com - August 9 at 5:55 PM
seekingalpha.com logoWhy did Arrowhead Pharmaceuticals stock pop up today? - Seeking Alpha
seekingalpha.com - June 29 at 5:17 PM
finance.yahoo.com logoForte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President - Yahoo Finance
finance.yahoo.com - June 7 at 11:18 AM
benzinga.com logoMetacrine shares are trading higher after the company reported Q1 earnings results. - Benzinga - Benzinga
benzinga.com - May 13 at 1:28 AM
finance.yahoo.com logoMetacrine Reports First-Quarter 2022 Results - Yahoo Finance
finance.yahoo.com - May 13 at 1:28 AM
finance.yahoo.com logoMetacrine Reports First-Quarter 2022 Results
finance.yahoo.com - May 13 at 1:28 AM
benzinga.com logoMetacrine Reports Fourth-Quarter 2021 Results - Benzinga - Benzinga
benzinga.com - March 31 at 8:04 PM
globenewswire.com logoMetacrine Reports Fourth-Quarter 2021 Results - GlobeNewswire
globenewswire.com - March 31 at 3:05 AM
finance.yahoo.com logoMetacrine Reports Fourth-Quarter 2021 Results
finance.yahoo.com - March 30 at 10:04 PM
streetinsider.com logoMetacrine Announces Executive Leadership Changes - StreetInsider.com
streetinsider.com - February 25 at 5:28 AM
seekingalpha.com logoMetacrine CFO steps down - Seeking Alpha
seekingalpha.com - February 25 at 12:27 AM
finance.yahoo.com logoMetacrine Announces Executive Leadership Changes
finance.yahoo.com - February 24 at 7:26 PM
benzinga.com logoMetacrine Reports It Remains On Track To Begin Phase 2 Trial In Ulcerative Colitis - Benzinga
benzinga.com - February 13 at 4:03 AM
finance.yahoo.com logoMetacrine To Slash Its Workforce By 50%
finance.yahoo.com - February 11 at 4:39 PM
finance.yahoo.com logoMetacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan
finance.yahoo.com - February 11 at 11:38 AM
nasdaq.com logoMetacrine Inc Shares Approach 52-Week Low - Market Mover - Nasdaq
nasdaq.com - January 8 at 6:30 AM
streetinsider.com logoDr. Hubert Chen Joins ADARx Pharmaceuticals as Chief Medical Officer - StreetInsider.com
streetinsider.com - January 7 at 8:33 AM
nasdaq.com logoMetacrine Inc Shares Approach 52-Week Low - Market Mover
nasdaq.com - December 30 at 8:33 AM
streetinsider.com logoUPDATE: Jefferies Assumes Metacrine Inc. (MTCR) at Hold - StreetInsider.com
streetinsider.com - December 29 at 8:19 AM
benzinga.com logoMetacrine shares are trading lower after the company announced the resignation of the Chief Medical Officer. - Benzinga
benzinga.com - December 27 at 7:05 PM
globenewswire.com logoMetacrine Announces Resignation of Chief Medical Officer - GlobeNewswire
globenewswire.com - December 27 at 8:46 AM
nasdaq.com logoMetacrine Inc Shares Close in on 52-Week Low - Market Mover - Nasdaq
nasdaq.com - December 26 at 6:09 PM
nasdaq.com logoTPG Pace Beneficial II Corp - Class A Shares Near 52-Week Low - Market Mover - Nasdaq
nasdaq.com - December 26 at 1:08 PM
nasdaq.com logoMetacrine Inc Shares Near 52-Week Low - Market Mover - Nasdaq
nasdaq.com - December 25 at 8:38 PM
nasdaq.com logoFrontier Investment Corp - Class A Shares Near 52-Week Low - Market Mover - Nasdaq
nasdaq.com - December 24 at 7:39 AM
nasdaq.com logoMetacrine Inc Shares Fall 8.3% Below Previous 52-Week Low - Market Mover - Nasdaq
nasdaq.com - December 24 at 12:16 AM
finance.yahoo.com logo4 Solid Retail Stocks to Buy in a Challenging Industry - Yahoo Finance
finance.yahoo.com - December 20 at 3:57 PM
nasdaq.com logoIs the Options Market Predicting a Spike in Metacrine (MTCR) Stock? - Nasdaq
nasdaq.com - December 20 at 10:55 AM
finance.yahoo.com logoIs the Options Market Predicting a Spike in Metacrine (MTCR) Stock?
finance.yahoo.com - December 20 at 10:55 AM
streetinsider.com logoForm 10-Q Metacrine, Inc. For: Sep 30 - StreetInsider.com
streetinsider.com - November 12 at 5:35 PM
finance.yahoo.com logoMetacrine Reports Third-Quarter 2021 Results - Yahoo Finance
finance.yahoo.com - November 12 at 12:34 PM
Get Metacrine News Delivered to You Automatically

Sign up to receive the latest news and ratings for MTCR and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:MTCR) was last updated on 1/31/2023 by MarketBeat.com Staff